✦ LIBER ✦

Photopheresis for the Prevention and Treatment of Transplant Rejection

✍ Scribed by MarkL. Barr

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 40 KB
Volume: 7
Category: Article
ISSN: 1203-4754
DOI: 10.1007/s10227-003-5004-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteristics of photopheresis treatme

Characteristics of photopheresis treatments for the management of rejection in heart and lung transplant recipients

✍ Hanh M. Khuu; Renee Desmond; Shu T. Huang; Marisa B. Marques 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract Photopheresis has been used in the management of rejection of heart and/or lung transplants. Although its mechanism of action remains unknown, irradiated T‐helper cell‐induced immunosuppression is the main theory. Since transplant recipients are often lymphopenic and lymphocytes are the

Biologics in the prevention and treatmen

Biologics in the prevention and treatment of graft rejection

✍ Marks, Reinhard ;Finke, Jürgen 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 184 KB

Treatment and prevention of bone marrow

Treatment and prevention of bone marrow transplant nephropathy

✍ John E. Moulder; Eric P. Cohen; Patricia Hill; Brian L. Fish 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Role of extracorporeal photopheresis in

Role of extracorporeal photopheresis in the treatment of cutaneous t-cell lymphoma, autoimmune disease, and allograft rejection

✍ Alain H. Rook; Jonathan T. Wolfe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Photopheresis is a pheresis-based therapy that is currently available at approximately 70 medical centers worldwide. Recent evidence indicates that extracorporeal photopheresis can significantly prolong life, as well as induce a 6&750/0 response rate among individuals with advanced cutaneous T-cell

Use of mycophenolate mofetil for prevent

Use of mycophenolate mofetil for prevention of acute rejection in renal transplantation

✍ S. Carl; M. Wiesel; G. Staehler 📂 Article 📅 1998 🏛 Springer 🌐 German ⚖ 208 KB

A randomized clinical trial of ursodeoxy

A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

✍ D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Acute rejection following orthotopic liver transplantation is a common problem despite current immunosuppressive regimens. Ursodeoxycholic acid (UDCA) has been shown in small, open-labeled studies to prevent rejection episodes, although its effects on complications such as infections, length of hosp